HB 2835 allows individuals convicted of drug-related felonies to access food assistance benefits (SNAP) if they meet specific conditions. To qualify, they must be in or completing approved substance abuse treatment, comply with court and probation requirements, avoid new drug offenses for one year, and pass voluntary sobriety tests. The bill directly affects people with past drug felony convictions who are actively working toward recovery through state-approved programs. It creates an exemption from a federal SNAP ineligibility rule for these individuals, using a state option permitted under federal law. The policy change applies only to those meeting all four criteria, not to individuals with additional drug convictions.
HB 2642 requires health insurance plans to cover nonopioid medications for acute pain without barriers, directly affecting people with health insurance (enrollees) and the plans themselves. The law prohibits plans from denying coverage for nonopioid drugs in favor of opioids, forcing patients to try opioids first, or charging higher costs for nonopioid options compared to opioids. It applies only to acute pain (expected to last 30 days or less) and takes effect for plans renewed or issued after January 1, 2027. The bill does not change provider prescribing practices but mandates equal treatment for nonopioid alternatives under insurance coverage.
HB 2817, the Veterans Mental Health Innovation Act, creates a state grant program to fund clinical trials using ibogaine for treating opioid use disorder and other mental health conditions. Eligible entities (like hospitals or research institutions within the state) must partner with a consortium that has submitted an FDA application for ibogaine trials, demonstrate relevant research experience, and match state grant funds with non-state funding. The bill establishes two dedicated state funds: an "Ibogaine Study Fund" for grant awards and an "Intellectual Property Fund" to collect revenue from trial-related patents or treatments, which will support veteran and at-risk population programs. It requires quarterly progress reports from grant recipients and annual legislative updates, with grant applications to begin accepting before November 1, 2026.
HB 3113 requires public buildings to store naloxone (an overdose reversal medication) in first aid kits and near defibrillators, and to inform occupants of its location and emergency procedures. It designates April as "Fentanyl Poisoning Awareness Month" and mandates school districts to establish drug-free advisory committees with community input, implement grade 6-12 fentanyl education, and develop prevention programs for students. The bill also directs law enforcement to investigate all drug-related deaths as homicide crime scenes, regardless of criminal charges, and to collaborate with schools on drug trafficking prevention in school zones. These provisions directly affect public buildings, school districts, and law enforcement agencies across Missouri.
SB 1539 - This act establishes the Missouri Guaranteed Inclusive Voluntary Exceptional Service (MO GIVES) Program under the Department of the National Guard (Department). The MO GIVES Program allows members of the Missouri National Guard who choose to become living organ donors to receive living donor medical orders for purposes of remaining on paid status during the living donation period. The Department shall approve a member's participation if sufficient funds are available and the member: (1) Is under Troop Program Unit status or Individual Ready Reserve status; (2) Is in good standing with the Department; (3) Either is not eligible for living donor paid leave from the member's employer or elects not to use any such employer-based benefit available to the member; (4) Specifies the type of donation; and (5) Agrees to undergo the procurement operation at a health care facility approved as a provider of continuing education points for transplant certification by the American Board for Transplant Certification. Upon approval of a member's application, the Department shall issue a living donor medical order, which shall: (1) Guarantee paid leave for the member for the living donation period, which shall not exceed 45 days unless an extension of time is deemed medically necessary by the primary surgical and medical recovery team; (2) Exempt the member from any requirement to use accrued annual or medical leave for the guaranteed paid living donation period; and (3) Provide a per diem allowance and a basic allowance for housing during the guaranteed paid living donation period based on the member's rank, region, and dependent status. This act also establishes the MO GIVES Fund, which consists of moneys used to fund the benefits provided under the MO GIVES Program. This act is identical to a provision in the perfected SS/SCS/SB 974 (2026), SB 1555 (2026), HB 2664 (2026), and HB 2943 (2026), and is similar to a provision in the truly agreed to and finally passed SS/SCS/HB 2593 (2026). KATIE O'BRIEN
HB 3099 expands prescribing authority for advanced practice registered nurses (APRNs), excluding nurse anesthetists, to include certain controlled substances. APRNs with a specific nursing board certificate and under collaborative practice agreements with physicians may now prescribe Schedule II-V controlled substances, including hydrocodone for hospice patients, but face restrictions: no self-prescribing, 120-hour supply limits for Schedule II/III medications, and strict written agreements required. The bill mandates detailed written collaborative agreements between APRNs and physicians, including location disclosures for patients and geographic proximity rules (with limited exceptions for rural areas and correctional facilities). It also allows APRNs to prescribe buprenorphine for addiction treatment up to 30 days without refill under physician direction.
This bill creates a grant program to fund FDA-approved clinical trials using ibogaine (a substance under review for treating opioid use disorder and mental health conditions). It requires state-based medical entities with specific research expertise, matching non-state funds, and partnerships with other states to apply for grants. The bill establishes two dedicated funds: one for grant disbursements and another to manage revenue from intellectual property rights generated by successful trials, with funds directed toward veterans and at-risk populations. It mandates quarterly reporting on trial progress and financials to the health department, while requiring physician supervision for ibogaine administration during trials.
HB 2602 proposes to exempt registered harm reduction programs from penalties for distributing needles/syringes under state drug laws. It creates a registration process through the Department of Health and Senior Services, requiring programs to partner with mental health/substance use treatment providers and avoid locations within 500 feet of schools (unless the school existed before the program opened). The bill directly affects registered syringe access programs, their staff, and volunteers who distribute or manufacture needles/syringes solely for these programs. This would make such activities legal under the law, removing criminal penalties for these specific actions. The bill is currently in early legislative stages (prefiled, first reading).
HB 1881 amends Missouri's controlled substances law by adding specific fentanyl analogs and synthetic opioids to Schedule I (not Schedule III, as the title states). The bill lists numerous fentanyl derivatives (e.g., acetyl fentanyl, xylazine is not listed) and opioid compounds under Schedule I, which requires they have high abuse potential and no accepted medical use. This change directly affects law enforcement, healthcare providers, and individuals handling these substances by classifying them as illegal under Missouri law. The bill does not mention xylazine in its text; the title appears to contain an error, as the actual provisions focus on fentanyl-related compounds. This is a substantive policy change to drug scheduling, not a procedural measure.
HB 2088 creates a court-ordered outpatient mental health treatment program for adults with severe mental disorders who cannot make informed decisions about treatment and meet specific criteria. The bill requires courts to order treatment if a person is 18+, suffers from a mental disorder, refuses voluntary care, and either poses a risk of serious harm (per §632.305) or has a documented history of non-compliance leading to detention or violent behavior within 36 months. Covered services include therapy, medication management, case coordination, crisis intervention, and assistance with housing or employment. The process streamlines court proceedings by requiring a hearing within two judicial days and eliminating notarization requirements for petitions. This law directly affects eligible adults in Missouri's judicial circuits who meet the defined criteria for court-ordered outpatient care.
